Researchers discover how stealthy HIV protein gets into cells

Key points
- Scientists have known for more than a decade that a protein associated with the HIV virus is good at crossing cell membranes, but they didn’t know how it worked.
- A paper describing their findings appears this month in Angewandte Chemie.
- The TAT protein transduction domain of the HIV virus has some remarkable properties.
- “TAT is extremely good at getting through cell membranes,” said materials science and engineering professor Gerard Wong, who led the new study.
Scientists have known for more than a decade that a protein associated with the HIV virus is good at crossing cell membranes, but they didn’t know how it worked. A multidisciplinary team from the University of Illinois has solved the mystery, and their findings could improve the design of therapeutic agents that cross a variety of membrane types.
A paper describing their findings appears this month in Angewandte Chemie.
The TAT protein transduction domain of the HIV virus has some remarkable properties. First, it is a tiny part of the overall TAT protein, containing only 11 amino acids. Second, and more important, it has an uncanny knack for slipping across membranes, those lipid-rich bags that form the boundaries of cells and cellular components and are designed to keep things out.
“TAT is extremely good at getting through cell membranes,” said materials science and engineering professor Gerard Wong, who led the new study. “You can attach TAT to almost anything and it will drag it across the membrane. It can work for virtually all tissues, including the brain.”
The TAT protein’s versatility makes it desirable as a drug-delivery device. It is already being used for gene therapy. (TAT is not involved in transmitting the HIV virus; it only aids the passage of other materials across the membranes of infected cells.)
Because it has so many potential uses, scientists have long endeavored to understand the mechanism that allows the TAT protein to work. But their efforts have been stymied by some baffling observations.
Six of its 11 residues are arginine, a positively charged amino acid that gives the protein its activity.
Most membranes are composed of a double layer of neutral, water-repellent lipids on their interiors, with hydrophilic (water-loving) “head groups” on their internal and external surfaces. The head groups generally carry a mildly negative charge, Wong said. Since opposites attract, it made sense to the researchers that the positively charged TAT protein would attract the negatively charged head groups on the surface of the membranes. This attraction could deform the membrane in a way that opened up a pathway through it.
If a short, positively charged protein was all that was needed for TAT to work, the researchers thought, then any positively charged amino acid should do the trick. But when they replaced the arginine in the protein with other positively charged amino acids, it lost its function. Clearly, a positive charge was not enough to make it work.
To get a better picture of the interaction of TAT with a variety of membranes, the researchers turned to confocal microscopy and synchrotron x-ray scattering (SAXS). Although sometimes used in biological studies, SAXS is more common to the fields of physics or materials science, where the pattern of X-ray scattering can reveal how atomic and nano scale materials are structured.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsEgypt discovers first case of potentially deadly MERS virus
Egypt has discovered its first case of the potentially deadly Middle East Respiratory Syndrome (MERS) in an Egyptian citizen who had recently returned from Saudi Arabia, Egypt's Ministry of Health said on Saturday. The…
29 April 2014
NewsSFU researchers trace HIV evolution in North America
A study tracing the evolution of HIV in North America involving researchers at Simon Fraser University has found evidence that the virus is slowly adapting over time to its human hosts. However, this change is so…
28 April 2014
NewsResearchers Look to Reduce Hep C Infections with "Staying Safe Intervention" for Injecting Drug Users
Despite a number of social/behavioral intervention and educational programs, the spread of hepatitis C (HCV) in people who inject drugs (PWIDs) remains a chronic problem. Now, researchers affiliated with New York…


